Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Swanton Wayne R
 2. Date of Event Requiring Statement (Month/Day/Year)
01/12/2018		 3. Issuer Name and Ticker or Trading Symbol
Allergan plc [AGN]
(Last)
(First)
(Middle)
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK,, COOLOCK, CO.		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP, Global Operations
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

DUBLIN, L2 D17 E400		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Ordinary Shares, par value $0.0001 742 (1)
D
 
Ordinary Shares, par value $0.0001 1,002 (2)
D
 
Ordinary Shares, par value $0.0001 888 (3)
D
 
Ordinary Shares, par value $0.0001 675 (4)
D
 
Ordinary Shares, par value $0.0001 327 (5)
D
 
Ordinary Shares, par value $0.0001 1,054 (6)
D
 
Ordinary Shares, par value $0.0001 1,252 (7)
D
 
Ordinary Shares, par value $0.0001 4,945 (8)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (9) 07/01/2024 Ordinary Shares 5,508 $ 224 D  
Stock Option (Right to Buy)   (10) 03/16/2025 Ordinary Shares 1,369 $ 307.51 D  
Performance-Based Restricted Stock Unit   (11)   (11) Ordinary Shares 12,129 $ (11) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Swanton Wayne R
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK,
COOLOCK, CO.
DUBLIN, L2 D17 E400		       EVP, Global Operations  

Signatures

/s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person 01/19/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes ordinary shares which were initially granted as restricted share units ("RSUs"). One-fourth of the total grant vested on each of March 5, 2015, March 5, 2016 and March 5, 2017 and such RSUs now constitute ordinary shares. One-fourth of the total grant will vest on March 5, 2018 and still represents RSUs.
(2) Includes ordinary shares which were initially granted as performance-based restricted share units ("PSUs"). One-fourth of the total grant vested on each of March 5, 2015, March 5, 2016 and March 5, 2017 and such PSUs now constitute ordinary shares. One-fourth of the total grant will vest on March 5, 2018 and represents RSUs.
(3) Includes ordinary shares which were initially granted as PSUs. One-third of the total grant vested on December 31, 2017 and such PSUs now constitute ordinary shares. One-third of the total grant will vest on each of December 31, 2018 and December 31, 2019 and represents RSUs.
(4) Includes ordinary shares which were initially granted as RSUs. One-fourth of the total grant vested on each of March 4, 2016 and March 4, 2017 and such RSUs now constitute ordinary shares. One-fourth of the total grant will vest on each of March 4, 2018 and March 4, 2019 and still represents RSUs.
(5) Includes ordinary shares which were initially granted as RSUs. One-fourth of the total grant vested on each of March 17, 2016 and March 17, 2017 and such RSUs now constitute ordinary shares. One-fourth of the total grant will vest on each of March 17, 2018 and March 17, 2019 and still represents RSUs.
(6) Includes ordinary shares which were initially granted as RSUs. One-fourth of the total grant vested on March 8, 2017 and such RSUs now constitute ordinary shares. One-fourth of the total grant will vest on each of March 8, 2018, March 8, 2019 and March 8, 2020 and still represents RSUs.
(7) Represents RSUs. One-fourth of the total grant will vest on each of March 7, 2018, March 7, 2019, March 7, 2020 and March 7, 2021.
(8) Represents RSUs. Twenty percent of the total grant will vest on each of December 12, 2018, December 12, 2019, December 12, 2020, December 12, 2021 and December 12, 2022.
(9) Twenty percent of the total grant vested on each of July 1, 2015, July 1, 2016 and July 1, 2017. Twenty percent of the grant will vest on each of July 1, 2018 and July 1, 2019.
(10) One-fourth of the total grant vested on each of March 17, 2016 and March 17, 2017. One-fourth of the grant will vest on each of March 17, 2018 and March 17, 2019.
(11) Represents PSUs which will vest as to fifty percent of total grant each on December 31, 2020 and December 31, 2021, subject to the achievement by the Issuer of certain performance criteria. Each PSU represents a contingent right to receive a number of ordinary shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.